Science & Enterprise subscription

Follow us on Twitter

  • Dexcom Inc., a maker of glucose monitoring systems, and University of Virginia are collaborating on extending the c… https://t.co/ZN7Zbhmh2s
    about 11 hours ago
  • New post on Science and Enterprise: Dexcom, UVirginia Partner on Diabetes Technology https://t.co/4V268unvtm #Science #Business
    about 11 hours ago
  • A biotechnology company is developing biologic treatments for Covid-19 infections in the gastrointestinal tract and… https://t.co/ChbVQfB86q
    about 1 day ago
  • New post on Science and Enterprise: DoD Funds Covid-19 G.I. Infection Therapy https://t.co/QsxvoCGCk8 #Science #Business
    about 1 day ago
  • A company developing messenger RNA therapeutics on demand from single-use biochips is raising $60 million in its se… https://t.co/gNxQafjlOS
    about 2 days ago

Please share Science & Enterprise

Sensor Patch Captures Health Indicators in Sweat

Runner silhouettes

A bio-engineering lab created a wearable fabric patch with threads configured into sensors that capture and measure health indicators from human sweat. . . . → Read More: Sensor Patch Captures Health Indicators in Sweat

Neuro Disease Start-Up Raises $73M in Early Funds

Neuron

A company developing new therapies for neurodegenerative diseases officially began operations, staked to $73 million raised in its first venture round. . . . → Read More: Neuro Disease Start-Up Raises $73M in Early Funds

Trial Testing Lymphoma Drug to Treat Covid-19

SARS-Cov-2 virus

A clinical trial is underway testing an experimental drug for lymphoma and neurological disorders also as a treatment for early Covid-19 infections. . . . → Read More: Trial Testing Lymphoma Drug to Treat Covid-19

Synthetic Protein Designed to Boost Covid-19 Vaccines

Jason McLellan and Daniel Wrapp

Researchers in Texas designed a synthetic version of a protein found on Covid-19 viruses that can make it easier to produce more vaccines. . . . → Read More: Synthetic Protein Designed to Boost Covid-19 Vaccines

Trial Testing Point-of-Care Covid-19 Diagnostic

A clinical trial in the U.K. is assessing a testing device to detect Covid-19 viruses in nasal swab samples that returns results in an hour. . . . → Read More: Trial Testing Point-of-Care Covid-19 Diagnostic

Start-Up Developing Inside-Cell Delivery, Gains $28.5M

Vesicles

A new company spun-off from Harvard University is developing techniques for delivering advanced genetic and protein therapies directly inside cells. . . . → Read More: Start-Up Developing Inside-Cell Delivery, Gains $28.5M

Tough Surgical Adhesive Commercially Licensed

Gel adhesive

A bio-materials company is acquiring the rights to develop dental sutures and membranes from an adhesive gel developed in a university lab. . . . → Read More: Tough Surgical Adhesive Commercially Licensed

Gene Therapy Production Company Opens, Raises $40M

Adeno-associated virus

A new enterprise developing and manufacturing gene therapies, both its own and for others, is underway, raising $40 million in venture funds. . . . → Read More: Gene Therapy Production Company Opens, Raises $40M

Oxford Covid-19 Vaccine Trial Invokes Immune Responses

Syrine ingloved hand

Results from a clinical trial testing a Covid-19 vaccine show the vaccine invokes two types of immune responses without serious adverse effects. . . . → Read More: Oxford Covid-19 Vaccine Trial Invokes Immune Responses

Infographic – Univ. Students Hope for Campus Return

Univ students pandemic chart

A poll by Axios suggests college and university students are ready to return to their campuses, and even postpone partying until the pandemic recedes. . . . → Read More: Infographic – Univ. Students Hope for Campus Return